Impact of RAS and BRAF mutations on carcinoembryonic antigen production and pattern of colorectal metastases

Table 1 RAS and BRAF status and patient demographics

			BRAF		BRAF		P	RAS		RAS		P
	All		MT		WT			MT		WT
	n	%	n	%	n	%		n	%	n	%
Age	< 60	87	50	5	6	82	94	1.00	44	51	43	49	1.00
	≥ 60	87	50	6	7	81	93		43	49	44	51
Gender	Male	103	59	3	3	100	97	0.052	49	48	54	52	0.54
	Female	71	41	8	11	63	89		38	54	33	46
Race	White	122	70	7	6	115	94	0.53	57	47	65	53	0.015
	Asian, PI	41	24	4	10	37	90		23	56	18	44
	Black	8	5	0	--	8	100		7	87	1	13
	Unknown	3	2	0	--	3	100		0	--	3	100

n: Number of patients; PI: Pacific Islander; MT: Mutant; WT: Wild type.